J
Juan Carlos Martínez Castrillo
Researcher at Hospital Universitario de Canarias
Publications - 30
Citations - 820
Juan Carlos Martínez Castrillo is an academic researcher from Hospital Universitario de Canarias. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 21 publications receiving 687 citations.
Papers
More filters
Journal ArticleDOI
The Nondeclaration of Nonmotor Symptoms of Parkinson's Disease to Health Care Professionals: An International Study Using the Nonmotor Symptoms Questionnaire
K. Ray Chaudhuri,Cristina Prieto-Jurcynska,Y. Naidu,Tanya Mitra,Belén Frades-Payo,S. Tluk,Anne Ruessmann,Per Odin,Graeme Macphee,Fabrizio Stocchi,William G. Ondo,Kapil D. Sethi,Anthony H.V. Schapira,Juan Carlos Martínez Castrillo,Pablo Martinez-Martin +14 more
TL;DR: The most frequently nondeclared symptoms of Parkinson's disease patients were delusions, daytime sleepiness, intense and vivid dreams, and dizziness, and in many, appropriate treatments for undeclared NMS were started only after these were recognised following completion of NMSQuest.
Journal ArticleDOI
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
Pedro J García-Ruiz,Juan Carlos Martínez Castrillo,Araceli Alonso-Canovas,Antonio Herranz Barcenas,Lydia Vela,Pilar Alonso,Marina Mata,Nuria Olmedilla Gonzalez,Ignacio Mahillo Fernandez +8 more
TL;DR: Since pramipexole, ropinirole and rotigotine are non-ergolinic DAs with very similar pharmacodynamic profiles, it is likely that other factors including route of administration (transdermal vs oral) explain the difference in risk of ICD development.
Journal ArticleDOI
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations
Claudia Trenkwalder,K. Ray Chaudhuri,Pedro J. Garcia Ruiz,Peter A. LeWitt,Regina Katzenschlager,Friederike Sixel-Doering,Tove Henriksen,Ángel Sesar,Werner Poewe,Mary Baker,Andres O. Ceballos-Baumann,Guenther Deuschl,Sophie Drapier,Georg Ebersbach,Andrew Evans,Hubert H. Fernandez,Stuart Isaacson,Teus van Laar,Andrew J. Lees,Simon J.G. Lewis,Juan Carlos Martínez Castrillo,Pablo Martinez-Martin,Per Odin,John D. O'Sullivan,Georgios Tagaris,Karoline Wenzel +25 more
TL;DR: This document outlines best-practice recommendations for selecting appropriate candidates for apomorphine intermittent injection (the pen-injection formulation) or apomorphicine continuous infusion (the pump formulation), for initiating patients onto therapy and for managing their ongoing treatment.
Journal ArticleDOI
Atypical parkinsonism with apraxia and supranuclear gaze abnormalities in type 1 Gaucher disease. Expanding the spectrum: case report and literature review.
Araceli Alonso-Canovas,Araceli Alonso-Canovas,Petra Katschnig,Arianna Tucci,Miryam Carecchio,Nicholas W. Wood,Mark J. Edwards,Juan Carlos Martínez Castrillo,Derek Burke,Simon Heales,Simon Heales,Kailash P. Bhatia +11 more
Journal ArticleDOI
Evolution of dose and response to botulinum toxin A in cervical dystonia: a multicenter study
Pedro J. Garcia Ruiz,Juan Carlos Martínez Castrillo,J.A. Burguera,Victor Campos,A. Castro,Esther Cancho,José R Chacón,Jaime Hernández Vara,Javier del Val,Elena Lopez Garcia,Francesc Miquel,Pilar Sanz,Lydia Vela +12 more
TL;DR: There is a statistically significant increase of mean dose of BoNT-A per session over time, and this could be explained by the appearance of secondary nonresponders, while those patients initially treated after 2000 did not show any statisticallysignificant increase in dose for 5 years.